Solventum Co. (NYSE:SOLV) Receives Average Recommendation of “Hold” from Analysts

Solventum Co. (NYSE:SOLV) has earned a consensus rating of “Hold” from the ten analysts that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $68.00.

A number of equities research analysts have issued reports on SOLV shares. Morgan Stanley upped their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. BTIG Research assumed coverage on Solventum in a report on Thursday, September 5th. They issued a “neutral” rating on the stock. Wells Fargo & Company lowered their price objective on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research report on Friday, August 9th. Stifel Nicolaus initiated coverage on Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price for the company. Finally, Piper Sandler increased their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th.

Solventum Stock Performance

Shares of Solventum stock opened at $68.39 on Thursday. Solventum has a twelve month low of $47.16 and a twelve month high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The business has a 50-day moving average price of $70.49 and a 200-day moving average price of $62.26.

Institutional Trading of Solventum

Hedge funds and other institutional investors have recently made changes to their positions in the business. Virtu Financial LLC purchased a new position in shares of Solventum in the third quarter worth $568,000. Toronto Dominion Bank grew its stake in Solventum by 1.6% during the 3rd quarter. Toronto Dominion Bank now owns 71,096 shares of the company’s stock valued at $4,957,000 after purchasing an additional 1,111 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Solventum by 4.0% in the third quarter. Geode Capital Management LLC now owns 3,347,719 shares of the company’s stock valued at $232,608,000 after purchasing an additional 128,317 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in shares of Solventum in the third quarter worth about $1,149,000. Finally, MML Investors Services LLC lifted its holdings in shares of Solventum by 3.2% during the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock worth $373,000 after purchasing an additional 168 shares during the period.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.